Ionizing radiation induces changes in profile of metabolites in serum of cancer patients

  • Małgorzata Roś-Mazurczyk Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
  • Anna Wojakowska Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
  • Łukasz Marczak Polish Academy of Science, Institute of Bioorganic Chemistry, Poznań
  • Krzysztof Polański University of Warvick, Coventry
  • Monika Pietrowska Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
  • Karol Jelonek Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
  • Iwona Domińczyk Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
  • Agata Hajduk Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
  • Tomasz Rutkowski Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
  • Krzysztof Składowski Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
  • Piotr Widłak Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
Keywords: head and neck cancer, mass spectrometry, metabolomics, radiation response, serum metabolome,

Abstract

Radiotherapy causes molecular changes observed at the level of body fluids, which are potential biomarker candidates for assessment of radiation exposure. Here we analyzed radiotherapy-induced changes in profile of small metabolites detected in sera of head and neck cancer patients using the GC/MS approach. There were about 30 compounds, including carboxylic acids, sugars, amines and amino acids, which levels significantly differed between pre-treatment and post-treatment samples. Among metabolites upregulated by radiotherapy was 3-hydroxy-butyric acid, which level increased about 10-fold in post-treatment samples. Compounds affected by irradiation were associated with several metabolic pathways, including catecholamine biosynthesis and amino acid metabolism.

References

Alsner J, Andreassen CN, Overgaard J (2008) Genetic markers for prediction of normal tissue toxicity after radiotherapy. Sem Radiat Oncol 18: 126–135. http://dx.doi.org/10.1016/j.semradonc.2007.10.004

Amundson SA, Bittner M, Fornace AJ, Jr (2003) Functional genomics as a window on radiation stress signaling. Oncogene 22: 5828-5833. http://dx.doi.org/10.1038/sj.onc.1206681

Bentzen SM (2008) From cellular to high-throughput predictive assays in radiation oncology: challenges and opportunities. Sem Radiat Oncol 18: 75–88. http://dx.doi.org/10.1016/j.semradonc.2007.10.003

Boguszewicz Ł, Hajduk A, Mrochem-Kwarciak J, Skorupa A, Ciszek M, Heyda A, Składowski K, Sokół M (2016) 1H NMR based metabolomic approach to monitoring of the head and neck cancer treatment toxicity. Metabolomics in press.

Goudarzi M, Mak TD, Chen C, Smilenov LB, Brennen DJ, Fornace AJ (2014) The effect of low dose rate on metabolomics response to radiation in mice. Radiat Environ Biophys 53: 645-657. http://dx.doi.org/10.1007/s00411-014-0558-1

Horneck G (1998) Biological monitoring of radiation exposure. Adv Space Res 22:1631-1641.

Jelonek K, Pietrowska M, Roś M, Zagdański A, Suchwałko A, Polańska J, Marczyk M, Rutkowski T, Skadowski K, Clench MR, Widak P. (2014) Radiation-induced changes in serum lipidome of head and neck cancer patients. Int J Mol Sci 15: 6609-6624. http://dx.doi.org/10.3390/ijms15046609

Laiakis EC, Strassburg K, Bogumil R, Lai S, Vreeken RJ, Hankemeier T, Langidge J, PlumbRS, Fornace AJ, Astarita G (2014a) Metabolic phenotyping reveals a lipid mediator response to ionizing radiation. J Prot Res 13: 4143-4154. http://dx.doi.org/10.1021/pr5005295

Laiakis EC, Mak TD, Anizan S, Amundson SA, Barker CA, Wolden SL, Brenner, DJ, Fornace AJ (2014b). Development of a Metabolomic Radiation Signature in Urine from Patients Undergoing Total Body Irradiation. Radiat Res 181: 350-361. http://dx.doi.org/10.1667/RR13567.1

Mak TD, Tyburski JB, Krausz KW, Kalinich JF, Gonzales FJ, Fornace AJ (2015) Exposure to ionizing radiation reveals global dose – and time-dependent changes in the urinary metabolome of rat. Metabolomics 11: 1082-1094. http://dx.doi.org/10.1007/s11306-014-0765-4

Marchetti F, Coleman MA, Jones IM, Wyrobek AJ (2006) Candidate protein biodosimeters of human exposure to ionizing radiation. Int J Radiat Biol 82: 605-639. http://dx.doi.org/10.1080/09553000600930103

McIntyre JO, Churchill P, Maurer A, Berenski CJ, Jung CY, Fleischer S (1983) Target size of D-beta-hydroxybutyrate dehydrogenase. Functional and structural molecular weight based on radiation inactivation. J Biol Chem 258: 953-959.

Menard C, Johann D, Lowenthal M, Muanza T, Sproull M, Ross S, Gulley J, Petricoin E, Coleman CN, Whiteley G, Liotta L, Camphausen K (2006) Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Res 66: 1844-1850.

Newman JC, Verdin E (2014) Ketone bodies as signaling metabolites. Trends Endocrinol Metab 25: 42-52. http://dx.doi.org/10.1016/j.tem.2013.09.002

Patel RM, Roback JD, Uppal K, Yu T, Jones AP, Josephson CD (2015) Metabolomics profile comparisons of irradiated and nonirradiated stored donor red blood cells. Transfusion 55: 544-552. http://dx.doi.org/10.1111/trf.12884

Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr, de Cabo R, Ulrich S, Akassoglou K, Verdin E (2013) Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339: 211-214. http://dx.doi.org/10.1126/science.1227166

Składowski K, Maciejewski B, Goleń M, Tarnawski R, Ślosarek K, Suwiński R, Sygula M, Wygoda A (2006) Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial Int J Radiat Oncol Biol Phys 66: 706-713. http://dx.doi.org/10.1016/j.ijrobp.2006.05.026

Spratlin JL, Serkova NJ, Eckhardt SG (2009) Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 15: 431-440. http://dx.doi.org/10.1158/1078-0432.CCR-08-1059

Wang C, Yang J, Nie J (2009) Plasma phospholipid metabolic profiling and biomarkers of rat following radiation exposure based on liquid chromatography-mass spectrometry technique. Biomed Chromatogr 23: 1079-1085. http://dx.doi.org/10.1002/bmc.1226

Widłak P, Pietrowska M, Polańska J, Rutkowski T, Jelonek K, Kalinowska-Herok M, Gdowicz-Kłosok A, Wygoda A, Tarnawski R, Składowski K (2013) Radiotherapy-related changes in serum proteome patterns of head and neck cancer patients; the effect of low and medium doses of radiation delivered to large volumes of normal tissue. J Translat Med 11: e299. http://dx.doi.org/10.1186/1479-5876-11-299

Widłak P, Jelonek K, Wojakowska A, Pietrowska M, Polanska J, Marczak Ł, Miszczyk L, Składowski K (2015) Serum Proteome Signature of Radiation Response: Upregulation of Inflammation-Related Factors and Downregulation of Apolipoproteins and Coagulation Factors in Cancer Patients Treated With Radiation Therapy - A Pilot Study. Int J Radiat Oncol Biol Phys 92(5): 1108-15. http://dx.doi.org/10.1016/j.ijrobp.2015.03.040

Published
2016-11-04
Section
Articles